Drug intelligence / Profile preview

Lingqihong

Development stage: Unknown
Lead developer: Jilin Fukang Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Lingqihong (灵芪红胶囊) is a proprietary traditional Chinese medicine (TCM) developed and marketed by Jilin Fukang Pharmaceutical. Formulated as an oral capsule, it is positioned as an exclusive health tonic. The product's name is derived from its primary herbal constituents, which typically include Ganoderma (Lingzhi), Astragalus (Huangqi), and Rhodiola (Hongjingtian). In the context of traditional Chinese medicine, these ingredients are utilized to replenish Qi, nourish the blood, and support the immune system. It is primarily indicated for general health support and the treatment of symptoms associated with Qi and blood deficiency, such as fatigue, dizziness, and palpitations. Lingqihong is an approved and marketed product in China.

Brand names: Lingqihong灵芪红胶囊
Other names: Lingqi Hong Jiaonang

Beyond the preview

Go deeper on Lingqihong.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lingqihong.

Explore the full profile